estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin]

RxCUI: 150840
RxNorm name: estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin]
Display name: PREMARIN (Oral Pill)
Full name: estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin]
Term type: SBD
Status: Active
Strength: 0.625 mg
Dose form: Tab
Route: Oral Pill
Updated: 2026-10-22 06:59:06

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 042005
Active start: 042005
Multiple ingredient: NO
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
estrogens, conjugated (USP)	0.625 MG / 1 EACH	estrogens, conjugated (USP)	estrogens, conjugated (USP)

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Tablet	317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
estrogens, conjugated (USP)	4099

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Premarin 0.625 MG Oral Tablet	1	NAMES
RxNorm Name	estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin]	1	NAMES
RxNorm Synonym	Premarin 0.625 MG Oral Tablet	1	NAMES
TTY	SBD	1	ATTRIBUTES
SPL_SET_ID	4 linked values 258e1602-a3cf-4ccc-ca80-73dbbfb812ff 701acf2c-fffe-451a-9b94-82d825e5a47c a3b86b85-8923-42ae-aa31-a66a6e090327 fd0c0836-5d23-2183-da81-9dc7f4287052	4	CODES
RxCUI	150840	1	CODES
MMSL_CODE	BD33	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0046-1102-52	0046-1102	Premarin estrogens, conjugated	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	NDA004782
0046-1102-81	0046-1102	Premarin estrogens, conjugated	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	NDA004782
0046-1102-91	0046-1102	Premarin estrogens, conjugated	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	NDA004782
50090-0167-0	50090-0167	Premarin estrogens, conjugated	A-S Medication Solutions	NDA004782
50090-0167-5	50090-0167	Premarin estrogens, conjugated	A-S Medication Solutions	NDA004782

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
NDA004782	0046-1102	Premarin estrogens, conjugated	NDA	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 2 · 179 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00046110252	rxnav_ndcs	yes
00046110281	rxnav_ndcs	yes
00046110291	rxnav_ndcs	yes
43353068860	rxnav_ndcs	yes
50090016700	rxnav_ndcs	yes
50090016705	rxnav_ndcs	yes
52959022330	rxnav_ndcs	yes
66105013710	rxnav_ndcs	yes
66267017430	rxnav_ndcs	yes
00008086706	rxnav_historical
00008086707	rxnav_historical
00008086781	rxnav_historical
00008086791	rxnav_historical
00008110206	rxnav_historical
00008110207	rxnav_historical
00008110251	rxnav_historical
00008110281	rxnav_historical
00008110291	rxnav_historical
00046086706	rxnav_historical
00046086707	rxnav_historical
00046086781	rxnav_historical
00046086791	rxnav_historical
00046086795	rxnav_historical
00046086799	rxnav_historical
00046110206	rxnav_historical
00046110207	rxnav_historical
00046110251	rxnav_historical
00046386781	rxnav_historical
00179117201	rxnav_historical
00179117230	rxnav_historical
00179117260	rxnav_historical
00179117290	rxnav_historical
00179190570	rxnav_historical
00179190571	rxnav_historical
00179190572	rxnav_historical
00247025100	rxnav_historical
00247025101	rxnav_historical
00247025130	rxnav_historical
00247025160	rxnav_historical
00247025190	rxnav_historical
00440817030	rxnav_historical
00440817090	rxnav_historical
00615058831	rxnav_historical
00615058839	rxnav_historical
00615058863	rxnav_historical
00855162150	rxnav_historical
11822520701	rxnav_historical
12280003900	rxnav_historical
12634040971	rxnav_historical
12634040979	rxnav_historical
24236092802	rxnav_historical
26053013101	rxnav_historical
35356010900	rxnav_historical
49999010900	rxnav_historical
49999010930	rxnav_historical
49999010990	rxnav_historical
51129244101	rxnav_historical
51129362401	rxnav_historical
51129362402	rxnav_historical
51655045221	rxnav_historical
51655045224	rxnav_historical
51655045225	rxnav_historical
51655045226	rxnav_historical
52959022300	rxnav_historical
53808077001	rxnav_historical
53978018908	rxnav_historical
53978018909	rxnav_historical
54569081200	rxnav_historical
54569081201	rxnav_historical
54569081202	rxnav_historical
54569081205	rxnav_historical
54569800600	rxnav_historical
54569800601	rxnav_historical
54569800602	rxnav_historical
54569850000	rxnav_historical
54569850001	rxnav_historical
54569850002	rxnav_historical
54868045100	rxnav_historical
54868045101	rxnav_historical
54868045102	rxnav_historical
54868045103	rxnav_historical
54868045104	rxnav_historical
54868045105	rxnav_historical
54868045106	rxnav_historical
54868045107	rxnav_historical
55154021300	rxnav_historical
55154021301	rxnav_historical
55154021307	rxnav_historical
55154021600	rxnav_historical
55154021604	rxnav_historical
55154021606	rxnav_historical
55289094307	rxnav_historical
55289094325	rxnav_historical
55289094328	rxnav_historical
55289094330	rxnav_historical
55887070230	rxnav_historical
57866668101	rxnav_historical
57866668102	rxnav_historical
57866668103	rxnav_historical
57866668105	rxnav_historical
58016094800	rxnav_historical
58016094801	rxnav_historical
58016094802	rxnav_historical
58016094803	rxnav_historical
58016094804	rxnav_historical
58016094807	rxnav_historical
58016094808	rxnav_historical
58016094809	rxnav_historical
58016094810	rxnav_historical
58016094812	rxnav_historical
58016094814	rxnav_historical
58016094815	rxnav_historical
58016094816	rxnav_historical
58016094818	rxnav_historical
58016094820	rxnav_historical
58016094821	rxnav_historical
58016094824	rxnav_historical
58016094825	rxnav_historical
58016094826	rxnav_historical
58016094827	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Premarin	ESTROGENS, CONJUGATED	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	258e1602-a3cf-4ccc-ca80-73dbbfb812ff	2026-06-04	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 0046-1102-52 ndc (package): 0046-1102-81 ndc (package): 0046-1102-91 ndc (product): 0046-1102 ndc11 (package): 00046110281 ndc11 (package): 00046110252 ndc11 (package): 00046110291 rxcui: 150840
Prempro	CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	fd0c0836-5d23-2183-da81-9dc7f4287052	2026-04-28	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 150840
Omeprazole	OMEPRAZOLE	Northwind Health Company, LLC	f3038133-8bb2-044e-e053-2995a90a6e7d	2026-01-01	Warnings, Adverse reactions	Exact identifier ndc11 (package): 51655045225 ndc11 (package): 51655045226
Premarin	ESTROGENS, CONJUGATED	A-S Medication Solutions	a3b86b85-8923-42ae-aa31-a66a6e090327	2025-04-02	Boxed warning, Warnings, Adverse reactions	Exact identifier ndc (package): 50090-0167-0 ndc (package): 50090-0167-5 ndc (product): 50090-0167 ndc11 (package): 50090016700 ndc11 (package): 50090016705 rxcui: 150840

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
fd0c0836-5d23-2183-da81-9dc7f4287052	PREMARIN 0.625 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] [SBD] · Premarin 0.625 MG Oral Tablet [SY]	3	39	These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995	20260428
a3b86b85-8923-42ae-aa31-a66a6e090327	PREMARIN 0.625 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] [SBD] · Premarin 0.625 MG Oral Tablet [SY]	3	23	These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942	20250402
b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea	PREMARIN 0.625 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] [SBD] · Premarin 0.625 MG Oral Tablet [SY]	3	3		20140508
701acf2c-fffe-451a-9b94-82d825e5a47c	PREMARIN 0.625 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] [SBD] · Premarin 0.625 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995	20121126
751b6213-92d8-40f8-a2d5-83e8dad086dd	PREMARIN 0.625 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] [SBD] · Premarin 0.625 MG Oral Tablet [SY]	3	1	PREMARIN ® (conjugated estrogens tablets, USP)	20120718
1fcd61a8-1a67-4785-a51a-45fca6fbb32b	PREMARIN 0.625 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] [SBD] · Premarin 0.625 MG Oral Tablet [SY]	3	1	PREMARIN ® (conjugated estrogens tablets, USP)	20100527

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
258e1602-a3cf-4ccc-ca80-73dbbfb812ff	These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. \| Pfizer Italia S.r.l. \| Pfizer Canada ULC \| Pfizer Ireland Pharmaceuticals Unlimited Company	20260604
258e1602-a3cf-4ccc-ca80-73dbbfb812ff	These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. \| Pfizer Italia S.r.l. \| Pfizer Canada ULC \| Pfizer Ireland Pharmaceuticals Unlimited Company	20260220
f3038133-8bb2-044e-e053-2995a90a6e7d	These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE CAPSULES. OMEPRAZOLE delayed-release capsules, for oral use Initial U.S. Approval: 1989	Northwind Health Company, LLC	20260101
a3b86b85-8923-42ae-aa31-a66a6e090327	These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942	A-S Medication Solutions	20250402
b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea		Physicians Total Care, Inc.	20140508
cbae4197-5e32-4de1-9816-9801c5d4e27b		National Council for Prescription Drug Programs	20130213
7cfb461b-a1f5-4d71-9c9a-13c81fba43ae		National Council for Prescription Drug Programs	20120724
fb689e79-4c4d-448d-97fc-585101b3edb6		National Council for Prescription Drug Programs	20120724
a7250132-3464-4fde-81b5-71ef325c6b9d		National Council for Prescription Drug Programs	20120724
86dc37bd-52f0-4209-b23e-21513f04789c		National Council for Prescription Drug Programs	20120724
8590f6a4-2b49-4b02-b399-7e728c3a9e66		National Council for Prescription Drug Programs	20120724
7d349a7f-705d-4415-a70f-9d22a703cd56		National Council for Prescription Drug Programs	20120724
09563355-fbd0-40bf-87fd-89b32b1aeef8		National Council for Prescription Drug Programs	20120724
6cc2d8d0-b2d3-49b1-b32f-b34b55af9b22		National Council for Prescription Drug Programs	20120724
684a65e2-4f84-478b-a628-1e7f973edcc3		National Council for Prescription Drug Programs	20120724
5e5aec38-4849-41e0-afe3-65cde0179c8c		National Council for Prescription Drug Programs	20120724
50394188-e747-418d-bb0c-a756a944a9db		National Council for Prescription Drug Programs	20120724
751b6213-92d8-40f8-a2d5-83e8dad086dd	PREMARIN ® (conjugated estrogens tablets, USP)	Aphena Pharma Solutions - Tennessee, Inc.	20120718
1fcd61a8-1a67-4785-a51a-45fca6fbb32b	PREMARIN ® (conjugated estrogens tablets, USP)	State of Florida DOH Central Pharmacy	20100527

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	G03CA	Natural and semisynthetic estrogens, plain	ATC1-4		estrogens, conjugated (USP)
FDASPL	D004966	Estrogens, Conjugated (USP)	CHEM	has_chemical_structure	estrogens, conjugated (USP)
FDASPL	N0000175825	Estrogen	EPC	has_epc	estrogens, conjugated (USP)
FDASPL	N0000000100	Estrogen Receptor Agonists	MOA	has_moa	estrogens, conjugated (USP)
MEDRT	D004966	Estrogens, Conjugated (USP)	CHEM	has_ingredient	estrogens, conjugated (USP)
MEDRT	D020152	Antithrombin III Deficiency	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D001943	Breast Neoplasms	DISEASE	may_treat	estrogens, conjugated (USP)
MEDRT	D001943	Breast Neoplasms	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D006470	Hemorrhage	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D019584	Hot Flashes	DISEASE	may_treat	estrogens, conjugated (USP)
MEDRT	D007006	Hypogonadism	DISEASE	may_treat	estrogens, conjugated (USP)
MEDRT	D008107	Liver Diseases	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D008594	Menopause, Premature	DISEASE	may_treat	estrogens, conjugated (USP)
MEDRT	D008595	Menorrhagia	DISEASE	may_treat	estrogens, conjugated (USP)
MEDRT	D009376	Neoplasms, Hormone-Dependent	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D015663	Osteoporosis, Postmenopausal	DISEASE	may_prevent	estrogens, conjugated (USP)
MEDRT	D011247	Pregnancy	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D016649	Primary Ovarian Insufficiency	DISEASE	may_treat	estrogens, conjugated (USP)
MEDRT	D011471	Prostatic Neoplasms	DISEASE	may_treat	estrogens, conjugated (USP)
MEDRT	D011655	Pulmonary Embolism	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D013923	Thromboembolism	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D013924	Thrombophlebitis	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	D020246	Venous Thrombosis	DISEASE	ci_with	estrogens, conjugated (USP)
MEDRT	N0000000100	Estrogen Receptor Agonists	MOA	has_moa	estrogens, conjugated (USP)
MEDRT	N0000008311	Bone Formation Stimulation	PE	has_pe	estrogens, conjugated (USP)
MEDRT	N0000009051	Gonadotropin Releasing Hormone Alteration	PE	has_pe	estrogens, conjugated (USP)
MEDRT	N0000009065	Hematologic Activity Alteration	PE	ci_pe	estrogens, conjugated (USP)
MEDRT	N0000009805	Pituitary Gland Activity Alteration	PE	has_pe	estrogens, conjugated (USP)
MEDRT	N0000009902	Vaginal Function Alteration	PE	has_pe	estrogens, conjugated (USP)
MEDRT	N0000000026	Hepatic Metabolism	PK	has_pk	estrogens, conjugated (USP)
MEDRT	N0000000042	Renal Excretion	PK	has_pk	estrogens, conjugated (USP)

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Premarin	rxnav_allrelated
DF	DF	Oral Tablet	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
DFG	DFG	Pill	rxnav_allrelated
GPCK	GPCK	{14 (estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 5 MG Oral Tablet) / 14 (estrogens, conjugated (USP) 0.625 MG Oral Tablet) } Pack	rxnav_allrelated
IN	IN	estrogens, conjugated (USP)	rxnav_allrelated
SBD	SBD	estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin]	rxnav_allrelated
SBDC	SBDC	estrogens, conjugated (USP) 0.625 MG [Premarin]	rxnav_allrelated
SBDF	SBDF	estrogens, conjugated (USP) Oral Tablet [Premarin]	rxnav_allrelated
SBDG	SBDG	Premarin Oral Product	rxnav_allrelated
SBDG	SBDG	Premarin Pill	rxnav_allrelated
SCD	SCD	estrogens, conjugated (USP) 0.625 MG Oral Tablet	rxnav_allrelated
SCDC	SCDC	estrogens, conjugated (USP) 0.625 MG	rxnav_allrelated
SCDF	SCDF	estrogens, conjugated (USP) Oral Tablet	rxnav_allrelated
SCDG	SCDG	estrogens, conjugated (USP) Oral Product	rxnav_allrelated
SCDG	SCDG	estrogens, conjugated (USP) Pill	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	0.625 MG
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	ANDA	ANDA075796
CODES	NDA	NDA004782
CODES	NDA	NDA020527
NAMES	Prescribable Synonym	PREMARIN 0.625 MG Oral Tablet
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon